| 今开：15.23 | 昨收：15.17 |
| 最高：15.45 | 最低：14.71 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.041412167E9 |
Cogent Biosciences(COGT)宣布已开始承销公开发行1.25亿美元的普通股。Cogent打算将此次发行的净收益用于与bezuclastinib和其他候选产品相关的开发、监管和商业准备活动，以及营运资金和一般公司用途。Jefferies、Piper Sandler& Co.和Gugge... 网页链接
$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000093751-23-000162 Act: 34 Size: 8 KB 网页链接
$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-007060 Act: 34 Size: 13 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-000615 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-23-000619 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001193125-22-302302 Act: 34 Size: 9 MB 网页链接
$Cogent Biosciences(COGT)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-22-024685 Act: 34 Size: 7 MB 网页链接
$Cogent Biosciences(COGT)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-22-024675 Act: 34 Size: 535 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032672 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-22-032661 Size: 5 KB 网页链接
$Cogent Biosciences(COGT)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-097869 Act: 34 Size: 75 KB 网页链接